Cedent Insurer

In insurance, a cedent insurer is a company that transfers part of its risk to another insurance company, known as a reinsurer. The cedent insurer is the primary insurer that issues policies to policyholders and assumes the risk associated with those policies.

Here are some key features of a cedent insurer:

  • Risk transfer: Cedent insurers transfer part of their risk to reinsurers in exchange for a premium payment. This allows them to reduce their exposure to losses and protect their financial stability.

  • Primary insurer: Cedent insurers are the primary insurer that issues policies to policyholders and assumes the risk associated with those policies.

  • Underwriting expertise: Cedent insurers have specialized knowledge of the risks associated with their policyholders and use that expertise to underwrite policies and set premiums.

  • Regulatory compliance: Cedent insurers are subject to state and federal regulations, such as solvency requirements and consumer protection laws, and must comply with these regulations to maintain their license and financial stability.

  • Service-oriented: Cedent insurers provide ongoing service and support to their policyholders, such as processing claims and answering insurance-related questions.

Example:

An example of a cedent insurer in insurance is a large property and casualty insurance company that issues homeowners insurance policies to policyholders. The insurer assumes the risk associated with those policies and collects premiums from policyholders in exchange for coverage. To manage their risk exposure, the insurer transfers part of their risk to a reinsurer, such as Swiss Re or Munich Re, in exchange for a premium payment. The reinsurer assumes part of the insurer's risk and helps to protect the insurer's financial stability. The insurer uses its underwriting expertise to evaluate risks and set premiums, and provides ongoing service and support to policyholders, such as processing claims and answering insurance-related questions.

Next Up

Welcome to our latest release. We are excited for you to try the new features.
According to Mployer Insights’ 2026 analysis of 50,000+ employer health plans, prescription drugs account for over 25% of total benefit expenses, with Tier 4 specialty drugs driving the majority of high-cost claims. While Tier 4 copays average $123 with coinsurance requirements in 31% of plans, individual oncology therapies like Darzalex Faspro ($170,800/yr) and Keytruda ($158,200/yr) frequently exceed average individual stop-loss deductibles ($141,938). To mitigate exposure, self-funded employers are increasingly turning to independent, transparent PBM models and biosimilar substitution—which yields up to a 73% net cost reduction per patient.
Most U.S. employers now offer paid maternity leave beyond the legal minimum, but coverage varies widely once you look past the basics. According to Mployer Insights' 2026 analysis of more than 50,000 employer benefit plans, 68% of employers provide paid maternity leave on top of short-term disability, typically adding 8 extra weeks, and half now cover 100% of salary during the disability period. Support drops off from there: only 41% of employers offer paid bonding leave for non-birth parents, and advanced family-building benefits remain even less common, with just 28% covering IVF and 11% offering adoption financial assistance. The data suggests that while baseline maternity leave has become standard, more comprehensive family-building support is still the exception rather than the norm.